Top companies’ include IsoPlexis, Hyperfine, Sema4′
The 2020 Fierce 15 list of companies includes Connecticut’s IsoPlexis and Hyperfine. The Forbes list of “America’s Best Startup Employers” includes Connecticut’s Sema4 … more
Home >
Access the latest news, business developments, company updates, industry trends, events and more.
The 2020 Fierce 15 list of companies includes Connecticut’s IsoPlexis and Hyperfine. The Forbes list of “America’s Best Startup Employers” includes Connecticut’s Sema4 … more
Yale spinout Artizan Biosciences, a New Haven biotech focused on curing inflammatory bowel disease, has raised $11 million in a financing round that includes an...
Nanoviricides reports that its two COVID-19 drug candidates have been “highly effective” against the virus in pre-clinical laboratory studies. The Shelton-based company is preparing a pre-IND...
BioCT believes that all people should experience dignity and respect in their personal lives and in their workplace. BioCT has established a board-level Equity, Diversity...
Rallybio is coming off an active year in 2020, when it moved its home office to New Haven’s Gold Building at 234 Church St., and...
SalivaDirect™ is an innovative and cost-effective saliva-based COVID-19 test developed by a team led by Wyllie and Nathan Grubaugh, an assistant professor at Yale School of Public...
The BioPath internship program is a now partnership between Southern Connecticut State University, Albertus Magnus College, Gateway Community College, the University of New Haven, and...
New Haven oncology biotech Cybrexa Therapeutics has agreed to work with the National Cancer Institute (NCI) on developing Cybrexa’s tumor-targeting drug, CBX-12. Under terms of...
3D-printed bone implants are being developed by A.D.A.M., a Farmington-based startup. The company, which operates out of office and lab space inside UConn’s Technology Incubation...
Vanessa Research (VR) supported Rare Disease Day for the fourth consecutive year last week. Rare Disease Day is observed internationally each year on the last...